Vega Therapeutics, Inc clinical trials
Acquired by Incyte Corporation, Jul 6, 2026 · source ↗
The registry lists 2 studies whose lead sponsor is Vega Therapeutics, Inc. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 14, 2026.
Before and after it joined Incyte Corporation
- First submitted before Vega Therapeutics, Inc became part of Incyte Corporation
- 2
- First submitted after Vega Therapeutics, Inc became part of Incyte Corporation
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Status
- Recruiting
- 2
Registry sponsor names on this page
- Vega Therapeutics, Inc2 studies
Something wrong with this grouping? Tell us on the Incyte Corporation page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Incyte Corporation studies →
- Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)RecruitingNCT07115004Phase 3
Sponsor listed in the registry: Vega Therapeutics, Inc · First submitted before Vega Therapeutics, Inc became part of Incyte Corporation
- Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)RecruitingNCT05776069Phase 1/2
Sponsor listed in the registry: Vega Therapeutics, Inc · First submitted before Vega Therapeutics, Inc became part of Incyte Corporation